Weighted Average Number of Shares Outstanding, Basic of Ernexa Therapeutics Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ernexa Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2025.
  • Ernexa Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 8.23M shares, a 2179% increase year-over-year.
  • Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 13.6M shares, a 157% increase from 2023.
  • Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.31M shares, a 74.2% increase from 2022.
  • Ernexa Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.05M shares, a 40.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Ernexa Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 8.23M +7.87M +2179% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 5.18M +4.82M +1335% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 53.4M +48M +886% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 13.6M +8.33M +157% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-12
Q3 2024 361K -5.05M -93.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 361K -4.94M -93.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 5.41M +283K +5.52% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 5.31M +2.26M +74.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-12
Q3 2023 5.41M +2.47M +84% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 5.3M +2.36M +80.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 5.13M +2.45M +91.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 3.05M +886K +40.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 2.94M +414K +16.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 2.94M -39.5M -93.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 2.68M +2.65M +9544% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 2.17M -15.4M -87.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 2.53M -15.1M -85.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 42.4M +24.9M +141% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 27.8K -17.5M -99.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-01
Q4 2020 17.6M Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 17.6M +14.8M +513% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 17.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 17.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 2.87M +17K +0.6% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-01
Q3 2018 2.86M +352K +14.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q3 2017 2.51M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q3 2013 71.2K +326 +0.46% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q4 2012 70.6K Oct 1, 2012 Dec 31, 2012 10-K 2013-03-29
Q3 2012 70.9K -60.3M -99.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 70.5K +10.1K +16.8% Apr 1, 2012 Jun 30, 2012 10-K 2013-03-29
Q1 2012 64.5K Jan 1, 2012 Mar 31, 2012 10-K 2013-03-29
Q3 2011 60.4M +195K +0.32% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 60.4K +200 +0.33% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-12
Q3 2010 60.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 60.2K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12

Ernexa Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 13.6M +8.33M +157% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-12
2023 5.31M +2.26M +74.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-12
2022 3.05M +886K +40.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 2.17M -15.4M -87.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 17.6M Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
2012 69K -60.3M -99.9% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-29
2011 60.4M +268K +0.45% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-30
2010 60.1M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.